JP2022507493A5 - - Google Patents

Info

Publication number
JP2022507493A5
JP2022507493A5 JP2021526472A JP2021526472A JP2022507493A5 JP 2022507493 A5 JP2022507493 A5 JP 2022507493A5 JP 2021526472 A JP2021526472 A JP 2021526472A JP 2021526472 A JP2021526472 A JP 2021526472A JP 2022507493 A5 JP2022507493 A5 JP 2022507493A5
Authority
JP
Japan
Application number
JP2021526472A
Other languages
Japanese (ja)
Other versions
JPWO2020099585A5 (https=
JP2022507493A (ja
Filing date
Publication date
Priority claimed from GBGB1818579.3A external-priority patent/GB201818579D0/en
Application filed filed Critical
Publication of JP2022507493A publication Critical patent/JP2022507493A/ja
Publication of JPWO2020099585A5 publication Critical patent/JPWO2020099585A5/ja
Publication of JP2022507493A5 publication Critical patent/JP2022507493A5/ja
Pending legal-status Critical Current

Links

JP2021526472A 2018-11-14 2019-11-14 新療法 Pending JP2022507493A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1818579.3 2018-11-14
GBGB1818579.3A GB201818579D0 (en) 2018-11-14 2018-11-14 New therapy
PCT/EP2019/081377 WO2020099585A1 (en) 2018-11-14 2019-11-14 New therapy

Publications (3)

Publication Number Publication Date
JP2022507493A JP2022507493A (ja) 2022-01-18
JPWO2020099585A5 JPWO2020099585A5 (https=) 2023-07-31
JP2022507493A5 true JP2022507493A5 (https=) 2023-07-31

Family

ID=64739449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021526472A Pending JP2022507493A (ja) 2018-11-14 2019-11-14 新療法

Country Status (10)

Country Link
US (1) US20220218736A1 (https=)
EP (1) EP3880303A1 (https=)
JP (1) JP2022507493A (https=)
KR (1) KR20210092719A (https=)
CN (1) CN113226461A (https=)
AU (1) AU2019378077A1 (https=)
BR (1) BR112021005645A2 (https=)
CA (1) CA3118899A1 (https=)
GB (1) GB201818579D0 (https=)
WO (1) WO2020099585A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4147688A1 (en) 2021-09-09 2023-03-15 InDex Pharmaceuticals AB Enema formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5149797A (en) 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
EP2596806A1 (en) * 2011-11-25 2013-05-29 Index Pharmaceuticals AB Method for prevention of colectomy
GB201707503D0 (en) * 2017-05-10 2017-06-21 Index Pharmaceuticals Ab New Therapy 3
GB201707500D0 (en) * 2017-05-10 2017-06-21 Index Pharmaceuticals Ab New therapy
GB201707501D0 (en) * 2017-05-10 2017-06-21 Index Pharmaceuticals Ab New therapy 2

Similar Documents

Publication Publication Date Title
BR112019017762A2 (https=)
BR112021017339A2 (https=)
BR112021018450A2 (https=)
BR112021017637A2 (https=)
BR112021017892A2 (https=)
BR112021017782A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021017738A2 (https=)
BR112021016996A2 (https=)
BR112021017728A2 (https=)
BR112021018452A2 (https=)
BR112021017703A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112021017732A2 (https=)
BR112021017234A2 (https=)
BR112021017355A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021017173A2 (https=)
BR112021017083A2 (https=)
BR112021018250A2 (https=)
BR112021017310A2 (https=)
BR112021018484A2 (https=)